BioCentury
ARTICLE | Financial News

Coherus raises $75M in follow-on

May 23, 2018 7:55 PM UTC

Coherus BioSciences Inc. (NASDAQ:CHRS) raised $75 million through the sale of 5.2 million shares at $14.50 in a follow-on underwritten by J.P. Morgan, Citigroup, Mizuho, Baird, Maxim Group and H.C. Wainwright.

The price is a 5% discount to the Coherus' close of $15.25 on Monday, when it proposed the offering after market hours. Coherus gained $0.15 to $15.40 on Tuesday, then slipped $0.10 to $15.30 on Wednesday...

BCIQ Company Profiles

Coherus BioSciences Inc.